Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers : an open-label clinical evaluation of efficacy

スポンサーリンク

概要

• 論文の詳細を見る
• 2000-05-01

著者

• Sibbald Gary

  Women's College Hospital

• EMBIL John

  the University of Manitoba

• PAPP Kim

  Probity Medical Research

• TOUSIGNANT Jacqueline

  Hopital Notre Dame

• SMIELL Janice

  The R. W. Johnson Pharmaceutical Research Institute

• WONG Betty

  Janssen-Ortho Inc.

• LAU Cathy

  Janssen-Ortho Inc.

関連論文

• Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers : an open-label clinical evaluation of efficacy
• Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers : a combined analysis of four randomized studies
• Becaplermin gelin the treatment of pressure ulcers : a phase II randomized, double-blind, placebo-controlled study

スポンサーリンク